World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 May 2023
Main ID:  RBR-33tdwy
Date of registration: 19/06/2017
Prospective Registration: No
Primary sponsor: Maternidade Escola Assis Chateaubriand
Public title: Sexual counseling for women who withdraw the breast
Scientific title: Intervention of Sexual Counselling for mastectomized: randomized controlled clinical trial
Date of first enrolment: 11/01/2017
Target sample size:
Recruitment status: Data analysis completed
URL:  http://ensaiosclinicos.gov.br/rg/RBR-33tdwy
Study type:  Intervention
Study design:  Clinical trial, randomized
Controlled, parallel, double blind, with 2 arms
 
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name: Natalia Gondim de   Almeida
Address:  Av. Dr. Silas Munguba, 1700 - Campus do Itaperi 60741-000 Fortaleza Brazil
Telephone: +55 (85) 3101 9601
Email: natygondim@gmail.com
Affiliation:  Universidade Estadual do Ceará
Name: Natalia  Gondim de   Almeida
Address:  Av. Dr. Silas Munguba, 1700 - Campus do Itaperi 60.741-000 Fortaleza Brazil
Telephone: +55 (85) 3101 9601
Email: natygondim@gmail.com
Affiliation:  Universidade Estadual do Ceará
Key inclusion & exclusion criteria
Inclusion criteria: Mastectomized women; To have at least six months of surgery; To be over 18 years of age;
To have started sexual activity

Exclusion criteria: Mastectomized women taking antidepressants; Mastectomized women with disabling diseases that prevent the sexual act.

Age minimum: 18Y
Age maximum: 100Y
Gender: F
Health Condition(s) or Problem(s) studied
M01.975
F01.145.802.975
Women, Mastectomy, Sexuality, Quality of life
E04.466
I01.800
Intervention(s)
Behavioural
V03.175.250
Experimental group: 9 mastectomized women will receive sexual counseling, based on the PILSET model, the intervention will be applied in weekly meetings for 5 weeks. Sessions will last for up to 2 hours. 1st meeting: permission (discussion on the theme and concerns about sexuality), 2nd meeting: limited information (clarifies on the physiology of sexual response and anatomy of the female genitalia, 3rd meeting: specific suggestion (advise and suggest changes in sexual behavior according to With criteria based on the physiology of the sexual response, and guide the change of attitude so that the woman goes on to have a more assertive behavior), 4th meeting: permission, limited information and specific suggestion (will resume aspects of the previous sessions and build history with fantasies Sexual intercourse), 5th meeting: sexual therapy (after closure the patient who needs it will be referred for sexual therapy). Control group: a group with 8 women will be provided, providing sexual counseling in oral explanation format, active control, performing a health education On sexuality, containing the same information used in the experimental group, in this group the information will be provided in a single meeting. Women will be compared by scoring scores from the Female Sexual Function Index (FSFI) and World Health
Organization Quality bref (WHOQOL-bre
F04.754.137
Primary Outcome(s)
Mean difference in the scoring scores of the World Health Organization Quality bref (WHOQOL-bref), From the observation of a variation of at least 10% in the pre- and post-intervention measurements
Mean difference in the scoring scores of the Female Sexual Function Index (FSFI), From the observation of a variation of at least 10% in the pre- and post-intervention measurements
Secondary Outcome(s)
Secondary outcomes are not expected
Secondary ID(s)
Source(s) of Monetary Support
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Secondary Sponsor(s)
Maternidade Escola Assis Chateaubriand
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history